JANPIX

Janpix is discovering and developing inhibitors of Signal Transducer and Activator of Transcription (“STAT”) proteins. Most members of this family of transcription factors have been known for some time and their relevance in certain cancers, in particular for STAT3 & STAT5, validated. Inhibiting the function of STAT proteins though has been very challenging thus far and Janpix developed new chemistry to address this complex problem.

#SimilarOrganizations #People #Financial #Website #More

JANPIX

Industry:

App Discovery Biotechnology Therapeutics

Founded:

2013-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.janpixbio.com

Total Employee:

Status:

Active

Total Funding:

27.67 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Office 365 Mail Microsoft Azure DNS GoDaddy DNS

Similar Organizations

cellugy-logo

Current Advisors List

francesco-rubertis_image

Francesco Rubertis Board Member @ Janpix
Board_member

giovanni-mariggi_image

Giovanni Mariggi Board Member @ Janpix
Board_member

sanford-zweifach_image

Sanford Zweifach Board Member @ Janpix
Board_member
2020-10-07

Current Employees Featured

patrick-t-gunning_image

Patrick T. Gunning
Patrick T. Gunning Chief Scientific Officer @ Janpix
Chief Scientific Officer

not_available_image

Pierre Cortes
Pierre Cortes Founder and CEO @ Janpix
Founder and CEO

roman-fleck_image

Roman Fleck
Roman Fleck CEO @ Janpix
CEO
2014-09-01

not_available_image

Kay Noel
Kay Noel VP Preclinical Development @ Janpix
VP Preclinical Development

Founder

patrick-t-gunning_image

Patrick T. Gunning

not_available_image

Pierre Cortes

Investors List

medicxi-ventures_image

Medicxi

Medicxi investment in Series B - Janpix

medicxi-ventures_image

Medicxi

Medicxi investment in Series A - Janpix

Official Site Inspections

http://www.janpixbio.com

Host Informations
Whois Informations

Loading ...